SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Aphton (apht)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: rocket who wrote (84)12/13/1998 1:46:00 AM
From: mason630   of 95
 
I agree, the trial must be going well for stomach cancer; Aphton has begun a new Phase III trial with SmithKline Beecham for pancreatic cancer. Morgan Stanley Dean Witter's report has a target price of $25, I believe. I guess this is for only one product because it seems a little low. I just wish the stock price would begin to reflect what the company is accomplishing and note how many products they have in their pipeline. I expect 1999 should be a rewarding year.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News